- United States
- /
- Capital Markets
- /
- NYSE:BX
How Investors Are Reacting To Blackstone (BX) Weighing an IPO or Sale of Ancestry.com

Reviewed by Sasha Jovanovic
- In late September 2025, Blackstone Inc. began considering multiple strategic options for Ancestry.com, including a possible Initial Public Offering or sale, inviting banks to pitch for a potential US$10 billion valuation of the genealogy platform, according to reports.
- This move underscores Blackstone's ongoing focus on unlocking value from technology-enabled businesses in its portfolio and adapting to changing market opportunities.
- We'll examine how Blackstone’s exploration of a value realization event for Ancestry.com may influence the company’s investment outlook.
AI is about to change healthcare. These 32 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
Blackstone Investment Narrative Recap
To own Blackstone, you must believe in its ability to generate strong earnings growth from alternative investments, capitalize on global capital flows, and execute profitable exits like Ancestry.com. The announcement that Blackstone is exploring a possible IPO or sale of Ancestry.com could serve as a short-term catalyst by highlighting the firm’s value realization strategy, but it does not change the fact that the pace and pricing of asset sales or IPOs remain vulnerable to market volatility, the biggest near-term risk for the company.
One recent announcement that stands out is Blackstone’s report of $62 billion in inflows in Q1 2025, reinforcing its fundraising strength. While this bolsters Blackstone's financial foundation and supports future earnings, it does not directly alter the uncertainties surrounding potential exits like Ancestry.com. Ultimately, strong fundraising remains a catalyst, but realization events are dependent on favorable market conditions.
In contrast, investors should be aware that while Blackstone’s bold moves to monetize assets seem promising, risks related to market volatility and delayed asset realization...
Read the full narrative on Blackstone (it's free!)
Blackstone's outlook anticipates $21.5 billion in revenue and $10.5 billion in earnings by 2028. This scenario assumes annual revenue growth of 16.7% and an earnings increase of $7.6 billion from current earnings of $2.9 billion.
Uncover how Blackstone's forecasts yield a $181.68 fair value, a 8% upside to its current price.
Exploring Other Perspectives
Some analysts are even more optimistic, forecasting Blackstone’s revenues to reach US$21.5 billion by 2028 driven by global expansion, tech-enabled innovation, and rapid fundraising. While consensus highlights value events like the Ancestry.com process, bullish views expect a much faster pace of revenue and earnings growth, showing just how much perspectives can diverge on where the company is headed next.
Explore 7 other fair value estimates on Blackstone - why the stock might be worth as much as 15% more than the current price!
Build Your Own Blackstone Narrative
Disagree with existing narratives? Create your own in under 3 minutes - extraordinary investment returns rarely come from following the herd.
- A great starting point for your Blackstone research is our analysis highlighting 2 key rewards and 3 important warning signs that could impact your investment decision.
- Our free Blackstone research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Blackstone's overall financial health at a glance.
Curious About Other Options?
Our top stock finds are flying under the radar-for now. Get in early:
- Trump's oil boom is here - pipelines are primed to profit. Discover the 22 US stocks riding the wave.
- Uncover the next big thing with financially sound penny stocks that balance risk and reward.
- The end of cancer? These 28 emerging AI stocks are developing tech that will allow early identification of life changing diseases like cancer and Alzheimer's.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Valuation is complex, but we're here to simplify it.
Discover if Blackstone might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.
Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
About NYSE:BX
Blackstone
An alternative asset management firm specializing in private equity, real estate, hedge fund solutions, credit, secondary funds of funds, public debt and equity and multi-asset class strategies.
High growth potential with solid track record.
Similar Companies
Market Insights
Community Narratives


